期刊文献+

端粒酶逆转录酶显性负突变体对乳腺癌细胞端粒酶活性的抑制作用 被引量:2

Inhibition of telomerase activity on breast cancer cells by dominant negative human telomerase reverase transcriptase gene
暂未订购
导出
摘要 目的:观察端粒酶逆转录酶显性负突变体(DN-hTERT)对乳腺癌细胞MCF7端粒酶活性的抑制作用。方法:将携带DN-hTERT基因的真核表达载体IRES2-EGFP空载体通过脂质体2000介导转入MCF7细胞,以G418进行稳定筛选,得到阳性克隆;倒置荧光显微镜观察转染细胞的生长情况;逆转录聚合酶链反应(RT-PCR)检测转染细胞hTERT mRNA的表达;TRAP-ELISA方法检测转染细胞端粒酶活性。结果:MCF7细胞转染DN-hTERT后生长受到抑制;转染DN-hTERT的MCF7细胞(MCF7/DN)hTERT mRNA表达升高;改进端粒重复序列扩增法(TRAP-ELISA)检测MCF7/DN细胞端粒酶活性与转染空载体MCF7细胞(MCF7/I)比较显著降低(P<0.05)。结论:DN-hTERT能特异性抑制MCF7细胞生长和端粒酶活性。 cancer cells MCF7 by :To explore inhibition of telomerase activity and malignant phenotype on breast Dominant Negative human telomerase reverase transcriptase gene (DN-hTERT). Methods: DN-hTERT eukaryotic expression vector DN-hTERT-IRES2-EGFP and empty vector (I) IRES2-EGFP were transfected into MCF7 by lipofectamine2000, after being selected by G418, positive clones were obtained; Tthe transfected cells growth was observed with inverted fluorescence microscope. The expression levels of hTERT mRNA of transfected cells were determined by reverse transcriptase polymerase chain reaction (RT-PCR). Telomerase activity of transfected cells was measured byTRAP-ELISE. Results:The proliferation of MCF7/DN cells were inhibited by DN-hTERT transtec- tion; The expression levels of hTERT mRNA increased in MCF7/DN. Telomeric length was shorter in MCF7/DN than that in MCF7/I. The telomerase activity measured by TRAP-ELISE was 2.36 +0.12 in MCF7/DN and was 3.32 ± 0.14 in vacant vector MCF7/I. The telomerase activity in MCF7/DN was significantly lower than in vacant vector transfected MCF7/I ( P 〈 0.05 ). Conclusion : DN-hTERT could inhibit malignant phenotype and telomerase activity on MCF7 cells.
出处 《医学研究生学报》 CAS 2007年第7期678-681,785,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30500596)
关键词 人端粒酶逆转录酶显性负突变体 端粒酶活性 乳腺癌 Dominant negative human telomerase reverase transcriptase gene Telomerase activity Breast cancer
  • 相关文献

参考文献13

  • 1Kim NW,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cells and cancer[ J].Science,1994,266(5193):2011-2015.
  • 2Feng J,Funk WD,Wang SS,et al.The RNA component of human telomerase[ J ].Science,1995,269 (5228):1236 -1241.
  • 3Mata JE,Joshi SS,Palen B,et al.A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo[ J ].Toxicol Appl Pharmacol,1997,144(1):189-197.
  • 4Meyerson M,Counter CM,Eaton EN,et al.hEST2,the putative human telomerase catalytic subunit gene,is up-regulated in tumor cells and during immortalization[ J ].Cell,1997,90 (4):785-795.
  • 5朱圣明,王艳萍,陈晓禾,唐小军,肖文.人端粒酶催化亚单位启动子驱动的EGFP真核表达载体的构建及在肺癌细胞的表达[J].医学研究生学报,2007,20(2):123-127. 被引量:11
  • 6Meyerson MJ.Role of telomerase in normal and cancer cells[ J ].Clin Oncol,2000,18 (13):2626-2634.
  • 7Yu J,Dubeau L.Telomerase and maliagnant transformation[J].Cancer Treat Res,2002,107 (2):213-228.
  • 8Meyerson M,Counter CM,Eaton EN,et al.bEST2,the putative human telomerase catalytic subunit gene,is up-regulated in tumor cells and immortalization[J].Cell,1997,90(4):785-795.
  • 9Cao Y,Li H,Mu FT,et al.Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension[ J].FASEB J,2002,16(1):96-98.
  • 10Wang ES,Wu K,Chin AC,et al.Telomerase inhibition with an oligonucleotide telomerase template antagonist:in vitro and in vivo studies in multiple myeloma and lymphoma[ J].Blood,2004,103(1):258-266.

二级参考文献14

  • 1孔北华,宋悦,马道新,曲迅,江森.人端粒酶逆转录酶启动子调控下胞嘧啶脱氨酶胸苷激酶融合基因治疗卵巢癌的体外研究[J].中华妇产科杂志,2004,39(6):390-395. 被引量:11
  • 2成俊,史晓峰,谢森,唐礼功,夏穗生.携带绿色荧光蛋白人转化生长因子基因真核表达载体的构建[J].医学研究生学报,2005,18(1):13-16. 被引量:8
  • 3王艳萍,唐小军,陈晓禾,车国卫,朱大兴,孙芝琳,周清华.hTERT启动子的克隆及其在端粒酶阳性肺癌细胞中的靶向转录活性研究[J].四川大学学报(医学版),2006,37(4):497-501. 被引量:7
  • 4李雷生,于红,张文卿.人单纯疱疹病毒加强型绿色荧光蛋白真核表达系统的构建及表达[J].医学研究生学报,2006,19(7):583-585. 被引量:6
  • 5Hirano T,Kaneko S,Kaneda Y,et al.HVJ-liposome-medited transfection of HSV-tk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice[J].Gene Therapy,2001,8(1):80-83.
  • 6Scholz IV,Cengic N,Baker CH,et al.Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer[J].Gene Ther,2005,12(3):272-280.
  • 7Lillehammer T,Tveito S,Engesaeter BO,et al.Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo-use of the human tyrosinase promoter with human enhancers[J].Cancer Gene Ther,2005,12(11):864-872.
  • 8Umeoda T,Kawashima T,Kagawa S,et al.Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluoresecent protein gene[J].Cancer Research,2004,64(17):6259-6256.
  • 9Toyota H,Kondo S,Koy S,et al.Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)[J].Anticancer Res,2006,26(1A):99-105.
  • 10Song JS,Kim HP.Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line[J].Oncol Rep,2004,12(2):443-447.

共引文献10

同被引文献48

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部